AXIM Moving Forward with CBD Trials for a Number of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AXIM Moving Forward with CBD Trials for a Number of Indications -- SECFilings.com

REDONDO BEACH, CA--(Marketwired - Oct 31, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an article discussing AXIM Biotechnologies' ( OTCQB : AXIM ) recently announced closing of a private funding round that will allow the company to continue clinical trials related to the treatment of a variety conditions. AXIM is focused on cannabinoids, and particularly the development of novel and more effective delivery methods for these and other compounds.

AXIM's CanChew® is the world's first patented controlled-release cannabinoid chewing gum and is currently available as an over-the-counter supplement. AXIM has taken things a step further with the development of MedChewRx™, the company's pharmaceutical candidate that combines cannabidiol (CBD) and tetrahydrocannabinol (THC), both naturally extracted and synthetic, in a patented controlled-release chewing gum.

The focus on chewing gum, and the patent behind this unique delivery method, is of particular interest. The company's researchers have proven that the act of chewing -- known as mastication in the medical community -- could also have neurological benefits. According to a growing body of research, the act of chewing could prevent cognitive dysfunction by changing internal carotid arterial blood flow and thereby increasing cerebral circulation/ perfusion. Chewing gum could therefore cause regional increases in neuronal activity that could be cognitively beneficial. Combined with the therapeutic action of the APIs (active pharmaceutical ingredients), MedChew Rx aims to improve the efficacy over existing medications.

AXIM is currently in the early stages of multiple Phase I-II trials to determine the efficacy of MedChew in the treatment of pain and spasticity related to multiple sclerosis as well as other indications, such as IBS, IBD and Crohn's disease. The recently secured funding should allow the company to complete these trials. Multiple sclerosis patients suffering from pain and spasms account for an estimated $4.8 billion market. Showing efficacy here would greatly enhance the value of the company.

AXIM also has a patent-pending drug called AX-1602 which is the world's first CBG (cannabigerol)/CBD-based candidate for treatment of psoriasis and atopic dermatitis currently undergoing clinical trials. These conditions affect over 20 million Americans and many more worldwide, and there is a dearth of effective treatments without harmful side effects.

Click here to read the full article: http://analysis.secfilings.com/articles/118-a...ndications

About SECFilings.com

Founded in 2004, SECFilings.com provides free real time filing alerts to over 600,000 registered members and offers services to help public companies grow their audience of interested investors.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns SECFilings.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx .

SECFilings.com Paul Archie 406-862-2242 parchie@secfilings.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 11

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 8

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 10

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 9

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 15

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 9

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations

Updated Category News Views 7

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 22

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 12

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 10

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Prepayments Data Released by Totalkredit A/S Today

Updated Category News Views 180

Prepayments Data Disclosure by Totalkredit A/S Totalkredit A/S is committed to transparency and timely communication of financial information. The company has shared its latest prepayment data under the designation CK93, showcasing essential insights into its financial operations. This report is directed to the stakeholders and the wider market to ensure everyone has...

Continue Reading
Bath & Body Works Welcomes 30,000 Seasonal Associates for Holidays

Updated Category News Views 76

Bath & Body Works Aims to Hire 30,000 Seasonal Associates This Holiday Season As the holiday season approaches, Bath & Body Works has some exciting news: the company plans to bring on board over 30,000 seasonal associates across its wide network of retail stores and distribution centers. With more than 1,800 locations across the country, as well as various distribution...

Continue Reading
Israeli Voters Favor Military Action Against Iranian Threats

Updated Category News Views 290

New Polling Reveals Strong Israeli Support for Military Strikes The Council for a Secure America (CSA) has recently published compelling findings from its public opinion research in Israel. The polling data indicates a significant majority of Israeli voters are in favor of carrying out military strikes aimed at disabling Iran's nuclear facilities. Public Opinion on...

Continue Reading
Fiscal Fourth Quarter Report: Vishay Intertechnology's Results Revealed

Updated Category News Views 160

Vishay Intertechnology's Financial Performance Overview MALVERN, Pa. — Vishay Intertechnology, Inc. (NYSE: VSH), recognized as a leading manufacturer of discrete semiconductors and passive electronic components, has released its financial results for the fourth quarter and the full fiscal year ending December 31, 2024. Key Highlights In the fourth quarter of 2024, the...

Continue Reading
Zscaler Reports Growth Yet Stock Drops 13% on Outlook

Updated Category News Views 100

Zscaler's Recent Performance and Stock Reaction Zscaler (NASDAQ: ZS) recently released its fourth-quarter results, showcasing a strong performance that, unfortunately, did not lead to a positive reaction in the stock market. The cloud security firm reported adjusted earnings per share of $0.88, surpassing analyst expectations of $0.70. Additionally, the company achieved...

Continue Reading